Mycoplasma pneumoniae Infections and Primary Immune Deficiencies

International Journal of Clinical Practice, 2022

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.1155/2022/6343818
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Mycoplasma pneumoniae ( M . pneumoniae ) is one of the leading causes of community‐acquired pneumonia in children and is also implicated in a variety of reactive extrapulmonary diseases. Recurrent and/or severe respiratory infections are one of the most frequent manifestations of several types of primary immunodeficiency. Here, we reviewed the medical literature to assess the potential relevance of M . pneumoniae in the infections observed in children affected with combined, humoral, and innate primary immune deficiencies. M . pneumoniae does not result to be epidemiologically prevalent as a cause of pneumonia in children affected by primary immunodeficiencies, but this infection can have a persistent or severe course in this category of patients. Indeed, the active search of M . pneumoniae could be useful and appropriate especially in children with humoral immune deficiencies. Indeed, most cases of M . pneumoniae infection in primary immunodeficiencies are described in patients affected by a/hypo‐gammaglobulinemia.